mhurhangee/ep-ind-claims huggingface dataset:
A tool for adjusting the size of an adjustable annuloplasty ring, comprising: a housing having an elongated opening; a scale provided on the housing adjacent the opening; a knob having a bore rotatably disposed within the opening in the housing about a barrel received within the bore, wherein rotation of the knob causes the knob to advance longitudinally within the opening along the barrel; a shaft extending into the bore coupled to the knob for rotation therewith and including a distal end adapted to engage an adjustable annuloplasty ring; and a pointer associated with the knob, wherein rotation of the knob causes the pointer to align with the scale to indicate the size of the adjustable annuloplasty ring corresponding to the scale aligned with the pointer. a housing having an elongated opening; a scale provided on the housing adjacent the opening; a knob having a bore rotatably disposed within the opening in the housing about a barrel received within the bore, wherein rotation of the knob causes the knob to advance longitudinally within the opening along the barrel; a shaft extending into the bore coupled to the knob for rotation therewith and including a distal end adapted to engage an adjustable annuloplasty ring; and a pointer associated with the knob, wherein rotation of the knob causes the pointer to align with the scale to indicate the size of the adjustable annuloplasty ring corresponding to the scale aligned with the pointer.
A method comprising: presenting, on a device, a view of at least part of an augmented reality, AR, environment, the AR environment including a first AR location (124, 128; 302) corresponding to a first physical location in a physical environment; initiating a download to the device of first data representing a first AR object (116, 118; 202) associated with the first AR location (124, 128; 302); assigning a size parameter to a first loading indicator (120; 200; 300; 400, 402, 404; 500, 502; 600A; 600B; 700) for the first AR object (116, 118; 202) based on a size of the first AR object (116, 118; 202); determining a spatial relationship between the view and the first physical location, wherein the spatial relationship indicates whether the first AR location (124, 128; 302) in the AR environment that corresponds to the first physical location is within the view; and presenting the first loading indicator (120; 200; 300; 400, 402, 404; 500, 502; 600A; 600B; 700) in the view, the first loading indicator having a size based on the assigned size parameter and being presented at a second AR location (122; 204; 304; 706) based on the determined spatial relationship, wherein said spatial relationship indicates whether or not the physical location is within the view. presenting, on a device, a view of at least part of an augmented reality, AR, environment, the AR environment including a first AR location (124, 128; 302) corresponding to a first physical location in a physical environment; initiating a download to the device of first data representing a first AR object (116, 118; 202) associated with the first AR location (124, 128; 302); assigning a size parameter to a first loading indicator (120; 200; 300; 400, 402, 404; 500, 502; 600A; 600B; 700) for the first AR object (116, 118; 202) based on a size of the first AR object (116, 118; 202); determining a spatial relationship between the view and the first physical location, wherein the spatial relationship indicates whether the first AR location (124, 128; 302) in the AR environment that corresponds to the first physical location is within the view; and presenting the first loading indicator (120; 200; 300; 400, 402, 404; 500, 502; 600A; 600B; 700) in the view, the first loading indicator having a size based on the assigned size parameter and being presented at a second AR location (122; 204; 304; 706) based on the determined spatial relationship, wherein said spatial relationship indicates whether or not the physical location is within the view.
An isolated plant cell comprising a disruption in at least: i) an endogenous CKX3 gene encoding for a cytokininoxidase/dehydrogenase comprising a polypeptide sequence being identical to or having at least 80% identity over the whole length of SEQ ID No. 1; and ii) in at least one further endogenous gene being: a) a CKX2 gene encoding for a cytokininoxidase/dehydrogenase comprising a polypeptide sequence being identical to or having at least 80% identity over the whole length of SEQ ID No. 2; b) a CKX4 gene encoding for a cytokininoxidase/dehydrogenase comprising a polypeptide sequence being identical to or having at least 80% identity over the whole length of SEQ ID No. 3; c) a CKX5 gene encoding for a cytokininoxidase/dehydrogenase comprising a polypeptide sequence being identical to or having at least 80% identity over the whole length of SEQ ID No. 4; or d) a CKX6 gene encoding for a cytokininoxidase/dehydrogenase comprising a polypeptide sequence being identical to or having at least 80% identity over the whole length of SEQ ID No. 5; wherein said disruptions inhibit expression and/or activity of a product of the at least two disrupted cytokininoxidase/dehydrogenase genes compared to a corresponding control plant cell lacking such disruptions. i) an endogenous CKX3 gene encoding for a cytokininoxidase/dehydrogenase comprising a polypeptide sequence being identical to or having at least 80% identity over the whole length of SEQ ID No. 1; and ii) in at least one further endogenous gene being: a) a CKX2 gene encoding for a cytokininoxidase/dehydrogenase comprising a polypeptide sequence being identical to or having at least 80% identity over the whole length of SEQ ID No. 2; b) a CKX4 gene encoding for a cytokininoxidase/dehydrogenase comprising a polypeptide sequence being identical to or having at least 80% identity over the whole length of SEQ ID No. 3; c) a CKX5 gene encoding for a cytokininoxidase/dehydrogenase comprising a polypeptide sequence being identical to or having at least 80% identity over the whole length of SEQ ID No. 4; or d) a CKX6 gene encoding for a cytokininoxidase/dehydrogenase comprising a polypeptide sequence being identical to or having at least 80% identity over the whole length of SEQ ID No. 5; a) a CKX2 gene encoding for a cytokininoxidase/dehydrogenase comprising a polypeptide sequence being identical to or having at least 80% identity over the whole length of SEQ ID No. 2; b) a CKX4 gene encoding for a cytokininoxidase/dehydrogenase comprising a polypeptide sequence being identical to or having at least 80% identity over the whole length of SEQ ID No. 3; c) a CKX5 gene encoding for a cytokininoxidase/dehydrogenase comprising a polypeptide sequence being identical to or having at least 80% identity over the whole length of SEQ ID No. 4; or d) a CKX6 gene encoding for a cytokininoxidase/dehydrogenase comprising a polypeptide sequence being identical to or having at least 80% identity over the whole length of SEQ ID No. 5;
A device for the treatment of a lavatory appliance which device generates a mist of a treatment composition which imparts a technical benefit to surfaces of the lavatory appliance which come into contact with the said aerosolized treatment composition, the device comprising: a mist generator means including an atomizing chamber, a control circuit for operating the mist generator means, a reservoir for the fluid product to be aerosolized, a means for supplying the mist generating means with the fluid product, a housing(129,170), and at least one flow directing nozzle, flow directing implement or flow directing orifice adapted to direct the flow of a mist generated by the mist generating means out from the housing(129,170) and towards part of a lavatory appliance, wherein that the atomizing chamber has a base, a generally perpendicular side wall which terminates at a top, the top extends from the side wall to an inner sidewall which is generally perpendicular to the top and extends downwardly or inwardly towards the base therefrom, until the inner sidewall terminates at an inner sidewall base, characterised in that the mist has a bi-modal distribution of fine particles, with a first portion having a particle size of 1-8 microns and a second portion having a particle size of 10-40 microns,
A method for preparing sintered NdFeB magnets, the method including the steps of: a) Preparing alloy flakes from a raw material of the NdFeB magnet by strip casting, then performing a hydrogen decrepitation of the alloy flakes to produce alloy pieces, then pulverization the alloy pieces to an alloy powder by jet mill, and finally cold isostatic pressing the alloy powder to a green compact while after applying a magnetic field; b) Putting the green compact into a vacuum furnace and performing a first sintering step, wherein the sintering temperature is in the range of 830°C to 880°C for 2 to 10 hours and the pressure in the furnace is 5×10 -1 Pa or less; c) Performing a second sintering step while applying a pressure along the magnetic orientation direction of the green compact achieved by step b), wherein the pressure applied on the green compact is in the range of 1MPa to 5MPa and the sintering temperature is in the range of 720°C to 850°C for 15 to 60 minutes, and wherein the temperature of the first sintering step is at least 10°C higher than the temperature of the second sintering step; and d) Subjecting the sintered magnet of step c) to an annealing treatment. a) Preparing alloy flakes from a raw material of the NdFeB magnet by strip casting, then performing a hydrogen decrepitation of the alloy flakes to produce alloy pieces, then pulverization the alloy pieces to an alloy powder by jet mill, and finally cold isostatic pressing the alloy powder to a green compact while after applying a magnetic field; b) Putting the green compact into a vacuum furnace and performing a first sintering step, wherein the sintering temperature is in the range of 830°C to 880°C for 2 to 10 hours and the pressure in the furnace is 5×10 -1 Pa or less; c) Performing a second sintering step while applying a pressure along the magnetic orientation direction of the green compact achieved by step b), wherein the pressure applied on the green compact is in the range of 1MPa to 5MPa and the sintering temperature is in the range of 720°C to 850°C for 15 to 60 minutes, and wherein the temperature of the first sintering step is at least 10°C higher than the temperature of the second sintering step; and d) Subjecting the sintered magnet of step c) to an annealing treatment.
An offset guide comprising: a body having a longitudinal axis and a curved surface arranged at an angle (θ) relative to the longitudinal axis; an arcuate portion extending from the body, the body and the arcuate portion defining an opening; a plurality of tabs extending from the arcuate portion into the opening, each of the plurality of tabs defining an aperture; a first fin extending from the body; and a second fin extending from the body and connected to the first fin via the curved surface of the body, the second fin extending parallel to the first fin from the body, wherein a channel sized to receive a guide rod is defined between an inner surface of the first fin, an inner surface of the second fin, and the curved surface. a body having a longitudinal axis and a curved surface arranged at an angle (θ) relative to the longitudinal axis; an arcuate portion extending from the body, the body and the arcuate portion defining an opening; a plurality of tabs extending from the arcuate portion into the opening, each of the plurality of tabs defining an aperture; a first fin extending from the body; and a second fin extending from the body and connected to the first fin via the curved surface of the body, the second fin extending parallel to the first fin from the body, wherein a channel sized to receive a guide rod is defined between an inner surface of the first fin, an inner surface of the second fin, and the curved surface.
A seal system for gas flow systems, the seal system comprising: two seal faces (29, 41); and a longitudinally compressible seal spring-biased between the seal faces (29, 41), the seal having a bellows configuration and opposite ends in sealing contact with the seal faces (29, 41); wherein at least one end of the seal is free to move relative to the corresponding seal face (29, 41) while maintaining the sealing contact; and wherein the faces (29, 41) are configured to allow substantial longitudinal movement relative to each other, substantial transverse movement relative to each other, and substantial tilting relative to each other; and further comprising: a stop means located on at least one seal face for limiting the transverse movement of the corresponding end of the seal. two seal faces (29, 41); and a longitudinally compressible seal spring-biased between the seal faces (29, 41), the seal having a bellows configuration and opposite ends in sealing contact with the seal faces (29, 41); wherein at least one end of the seal is free to move relative to the corresponding seal face (29, 41) while maintaining the sealing contact; and wherein the faces (29, 41) are configured to allow substantial longitudinal movement relative to each other, substantial transverse movement relative to each other, and substantial tilting relative to each other; and further comprising: a stop means located on at least one seal face for limiting the transverse movement of the corresponding end of the seal. a stop means located on at least one seal face for limiting the transverse movement of the corresponding end of the seal.
Compound having the general structure III: wherein R 1, R 2, R 3, R 4, R 5, R 6, R 7 and R 8 are each independently selected from: -H, - (C 1 -C 12) alkyl, -O- (C 1 -C 12) alkyl, -O- (C 6 -C 20) aryl, -(C 6 -C 20)aryl, -Cl, -F, -Br, -I, -COO-(C 1 -C 12)alkyl, -CONH- (C 1 -C 12) alkyl, -(C 6 -C 20) aryl-CON[(C 1 -C 12)alkyl] 2, -CO- (C 1 -C 12) alkyl, -CO- (C 6 -C 20) aryl, -COOH, -OH, -SO 3 H, -SO 3 Na, -NO 2, -CN, -NH 2, -N[(C 1 -C 12)alkyl] 2; and wherein R 9, R 10, R 11, R 12, R 13, R 14, R 15 and R 16 are each independently selected from: -H, -(C 1 -C 12) alkyl, -O-(C 1 -C 12)alkyl, -O-(C 6 -C 20)aryl, -(C 6 -C 20)aryl, -Cl, -F, -Br, -I, -COO-(C 1 -C 12)alkyl, -CONH-(C 1 -C 12) alkyl, -(C 6 -C 20)aryl-CON[(C 1 -C 12)alkyl] 2, -CO-(C 1 -C 12) alkyl, -CO-(C 6 -C 20)aryl, -COOH, -OH, -SO 3 H, -SO 3 Na, -NO 2, -CN, -NH 2, -N[(C 1 -C 12)alkyl] 2. wherein R 1, R 2, R 3, R 4, R 5, R 6, R 7 and R 8 are each independently selected from: -H, - (C 1 -C 12) alkyl, -O- (C 1 -C 12) alkyl, -O- (C 6 -C 20) aryl, -(C 6 -C 20)aryl, -Cl, -F, -Br, -I, -COO-(C 1 -C 12)alkyl, -CONH- (C 1 -C 12) alkyl, -(C 6 -C 20) aryl-CON[(C 1 -C 12)alkyl] 2, -CO- (C 1 -C 12) alkyl, -CO- (C 6 -C 20) aryl, -COOH, -OH, -SO 3 H, -SO 3 Na, -NO 2, -CN, -NH 2, -N[(C 1 -C 12)alkyl] 2; and wherein R 9, R 10, R 11, R 12, R 13, R 14, R 15 and R 16 are each independently selected from: -H, -(C 1 -C 12) alkyl, -O-(C 1 -C 12)alkyl, -O-(C 6 -C 20)aryl, -(C 6 -C 20)aryl, -Cl, -F, -Br, -I, -COO-(C 1 -C 12)alkyl, -CONH-(C 1 -C 12) alkyl, -(C 6 -C 20)aryl-CON[(C 1 -C 12)alkyl] 2, -CO-(C 1 -C 12) alkyl, -CO-(C 6 -C 20)aryl, -COOH, -OH, -SO 3 H, -SO 3 Na, -NO 2, -CN, -NH 2, -N[(C 1 -C 12)alkyl] 2.
An inkjet recording device comprising: a nozzle configured to eject ink; a pressure generator configured to change pressure on ink in an ink flow path that communicates with the nozzle by a predetermined drive operation; and a driver configured to operate the pressure generator, wherein the driver is configured to make the pressure generator perform the drive operation predetermined times of at least twice at time points on a predetermined cycle, and to make the nozzle eject an ink droplet of an amount corresponding to a number of drive operations included in a set of drive operations, in a case in which the number of drive operations is two, the driver is configured to make the pressure generator perform the drive operation twice with an interval twice as long as the cycle, the drive operation includes a first operation of increasing a volume of the ink flow path and a second operation of reducing the increased volume, and in a last drive operation in the set of drive operations, a period between a start time point of the first operation and a start time point of the second operation is determined in accordance with a delay time related to displacement of ink in the ink flow path in response to the drive operation, characterized in that the delay time is 0.55 to 0.70 times as long as a natural vibration period of ink in the ink flow path. a nozzle configured to eject ink; a pressure generator configured to change pressure on ink in an ink flow path that communicates with the nozzle by a predetermined drive operation; and a driver configured to operate the pressure generator, wherein the driver is configured to make the pressure generator perform the drive operation predetermined times of at least twice at time points on a predetermined cycle, and to make the nozzle eject an ink droplet of an amount corresponding to a number of drive operations included in a set of drive operations, in a case in which the number of drive operations is two, the driver is configured to make the pressure generator perform the drive operation twice with an interval twice as long as the cycle, the drive operation includes a first operation of increasing a volume of the ink flow path and a second operation of reducing the increased volume, and in a last drive operation in the set of drive operations, a period between a start time point of the first operation and a start time point of the second operation is determined in accordance with a delay time related to displacement of ink in the ink flow path in response to the drive operation, characterized in that the delay time is 0.55 to 0.70 times as long as a natural vibration period of ink in the ink flow path.
An in vitro method of increasing proliferation of a neural stem cell comprising a step of transfecting said neural stem cell with a gene that activates Notch signalling and culturing the neural stem cell, wherein the gene encodes NICD (Notch Intra Cellular Domain) having an amino acid sequence set forth in SEQ ID NO.2, and the transfected cell shows increased proliferation compared to a non-transfected cell.
A fuel supply method for a gas turbine combustor which supplies at least two kinds of fuels different in calorie to the gas turbine combustor, wherein, at a time of start of operation of the gas turbine, with use of both a first fuel supply system which supplies a high-calorific fuel to a first nozzle of the gas turbine combustor, and a second fuel supply system which supplies a low-calorific fuel to a second nozzle of the gas turbine combustor, the high-calorific fuel and the low-calorific fuel are supplied to the gas turbine combustor, and wherein, at a time point when the gas turbine reaches output power which enables continuous operation with only the low-calorific fuel, supply of the high-calorific fuel to the gas turbine combustor is shut off, and only the low-calorific fuel is supplied to the gas turbine combustor, characterised in that at said time point the low-calorific fuel guided through the second fuel supply system is guided to the first nozzle through a sweep line which guides the low-calorific fuel to a mid-portion of the first fuel supply system, and the low-calorific fuel is ejected from both the second nozzle and the first nozzle.
A non-therapeutic method for the treatment and/or prevention of hair loss comprising the following steps in any order: (a) topically applying a composition comprising minoxidil to the scalp and leaving the composition in contact with the scalp for 5 to 15 h; (b) topically applying a composition comprising a surfactant and optionally caffeine to the scalp and leaving the composition in contact with the scalp for 1 to 10 minutes; and at least in case when composition does not comprise caffeine (c) topically applying a composition comprising caffeine to the scalp and leaving the composition in contact with the scalp for at least 6 h. (a) topically applying a composition comprising minoxidil to the scalp and leaving the composition in contact with the scalp for 5 to 15 h; (b) topically applying a composition comprising a surfactant and optionally caffeine to the scalp and leaving the composition in contact with the scalp for 1 to 10 minutes; and at least in case when composition does not comprise caffeine (c) topically applying a composition comprising caffeine to the scalp and leaving the composition in contact with the scalp for at least 6 h.
A tool for implanting an interphalangeal implant, the tool comprising: a limb support for supporting a phalangeal limb; a driving rod, wherein the driving rod is movable for moving the interphalangeal implant towards the limb support; and an actuation mechanism for actuating the driving rod. a limb support for supporting a phalangeal limb; a driving rod, wherein the driving rod is movable for moving the interphalangeal implant towards the limb support; and an actuation mechanism for actuating the driving rod.
Concrete screw, having a threaded portion with a central core diameter d Km that is substantially constant over at least half of the length, a thread-free shank portion and a tool-application means, especially a hexagonal head, characterised in that in a transition region of the threaded portion which is adjacent to the shank portion, over a length that corresponds to at least half the thread pitch (p), especially at least the thread pitch (p) and preferably at least twice the thread pitch (p), the core diameter d K increases from the central core diameter d Km in the direction of the shank portion to the diameter d s of the shank portion.
An oncotic pressure-increasing macromolecule which is a protein macromolecule or a non-protein macromolecule of 25 kDa or more which does not recognize VEGF, as an active ingredient in a composition for its use by intravitreous injection, for treating macular edema, wherein the protein macromolecule is selected in the group consisting of albumin, gelatin, alpha2 macroglobulin, fibrinogen, haptoglobin multimers, beta lipoproteins and antibodies or antibodies fragments that do not bind to a human protein and wherein the non- protein macromolecule is selected in the group consisting of dextran and hydroxyethyl starch.
A method of manufacturing a synthesis gas by using a synthesis plant comprising a reformer having a steam reforming reaction tube, a combustion radiation portion provided around the reaction tube, for heating the reaction tube by combusting fuel, and a convection portion communicating with the combustion radiation portion, the method comprising the steps of: adding steam to a natural gas to prepare a steam-containing natural gas; passing the steam-containing natural gas through the convection portion of the reformer, thereby preheating the steam-containing natural gas up to a first temperature which would not decompose hydrocarbons of C 2 or more existing in the natural gas; preheating carbon dioxide up to a second temperature of 550°C to 650°C, which is higher than the first temperature by passing the carbon dioxide through the convection portion of the reformer; and feeding the steam-containing natural gas preheated and the carbon dioxide preheated to the reaction tube, thereby producing a synthesis gas containing hydrogen and carbon monoxide. adding steam to a natural gas to prepare a steam-containing natural gas; passing the steam-containing natural gas through the convection portion of the reformer, thereby preheating the steam-containing natural gas up to a first temperature which would not decompose hydrocarbons of C 2 or more existing in the natural gas; preheating carbon dioxide up to a second temperature of 550°C to 650°C, which is higher than the first temperature by passing the carbon dioxide through the convection portion of the reformer; and feeding the steam-containing natural gas preheated and the carbon dioxide preheated to the reaction tube, thereby producing a synthesis gas containing hydrogen and carbon monoxide.